Marimed (MRMD) Free Cash Flow Growth (3y) (2016 - 2026)
Marimed (MRMD) Free Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 14.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 216.31% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.08% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 49.44% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -10.40% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -9.38% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 134.18% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | 141.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 141.88% |
| Mar 31, 2026 | 30.21% |
| Dec 31, 2025 | 4.06% |
| Sep 30, 2025 | -15.06% |
| Jun 30, 2025 | 44.59% |
| Mar 31, 2025 | -38.78% |
| Dec 31, 2024 | 47.64% |
| Sep 30, 2024 | -27.12% |
| Jun 30, 2024 | -40.93% |
| Mar 31, 2024 | -26.48% |
| Dec 31, 2023 | -33.53% |
| Sep 30, 2023 | 88.72% |
| Jun 30, 2023 | -30.94% |
| Mar 31, 2023 | -36.27% |
| Dec 31, 2022 | -34.90% |
| Sep 30, 2022 | 34.92% |
| Jun 30, 2022 | 25.11% |
| Mar 31, 2022 | 37.09% |
| Dec 31, 2021 | -50.07% |
| Sep 30, 2021 | 68.14% |